CLINICAL_TRIALS
trial_result
· 2020-09-25
Clinical Trial Update: Flortaucipir PET Imaging in Subjects With FTD [Phase 1]
Summary
Phase 1 trial updating Flortaucipir PET imaging in subjects with Frontotemporal Dementia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Avid Radiopharmaceuticals | Conditions: Frontotemporal Dementia | Phase 1 | Status: COMPLETED | Results posted: 2020-09-25